NCT02558790View on ClinicalTrials.gov

L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Attention Deficit/Hyperactivity DisorderADHD
Interventions
DRUG

L-Threonic Acid Magnesium Salt (L-TAMS)

Trial Locations (1)

02144

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Neurocentria, Inc.
All Listed Sponsors
collaborator

Neurocentria, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT02558790 - L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD | Biotech Hunter | Biotech Hunter